MedPath

The Influence of Endometrial Suturing on the Risk of Uterine Scar Defect

Not Applicable
Completed
Conditions
Cesarean Wound Disruption
Interventions
Procedure: Endometrial suturing
Procedure: Non- endometrial suturing
Device: Vaginal ultrasonography
Other: Questionnaire
Registration Number
NCT03851003
Lead Sponsor
Sheba Medical Center
Brief Summary

Caesarean section (CS) is the commonest major operation performed on women worldwide with progressively rising incidence. Consequently, long-term adverse sequelae due to uterine scar defect have been increasing. Given the association between uterine scar defect and gynecological symptoms, obstetric complications and potentially with subfertility, it is important to elucidate the etiology in order to develop preventive strategies. Surgical technique of uterine incision closure seems to be the most important determinant of defect formation. The aim of this prospective randomized study is to evaluate specifically the influence of inclusion versus exclusion of the endometrium during suturing the uterine incision on the risk to develop uterine scar defect.

Detailed Description

Caesarean section (CS) is the commonest major operation performed on women worldwide with progressively rising incidence. Consequently, long-term adverse sequelae due to uterine scar defect have been increasing. Common gynecological complains include chronic pelvic pain, dyspareunia, dysmenorrhea and postmenstrual spotting and infertility. Obstetric sequelae seem to be increasing such as cesarean scar ectopic pregnancy, placenta previa, and placenta accrete, all associated with major maternal morbidity and even mortality. Given the association between uterine scar defect and gynecological symptoms, obstetric complications and potentially with subfertility, it is important to elucidate the etiology in order to develop preventive strategies. Probable risk factors suggested are single-layer myometrium closure, multiple CSs and uterine retroflexion, however, surgical technique of uterine incision closure seems to be the most important determinant of defect formation. It is proposed that continuous, non-locking absorbable sutures in two layers, without including much of decidua and without undue tight (constricting) pulling of sutures are likely to result in good healing of uterine scar. The aim of this prospective randomized study is to evaluate specifically the influence of inclusion versus exclusion of the endometrium during suturing the uterine incision on the risk to develop uterine scar defect.

Material and Methods Prospective randomized single blinded study conducted in a single tertiary center. All women at term (≥37 weeks of gestation) with singleton pregnancy that are about to go threw cesarean section attending the pre- operative clinics, will be offered to participate in the study. After signing informed consent, women will be block randomized for one of two groups: A- uterine incision repair including suturing of the endometrium, B - uterine incision repair without including the endometrium. All operation will be performed by a single highly skilled obstetrician. All other stages of operations will be similar in both of the groups including: low segment incision, delivery of the fetus and the placenta, uterine revision, intraperitoneal uterine repair, use of stratafix thread in double layer suturing. Operative and post operative data will be collected from the medical files including: operation duration, estimated blood loss, operation complications ( hypotension, bladder gut or vascular perforation ) , post operative complications ( hemorrhage, endometritis, vascular - thromboembolic event, ileus ). All women will be invited to the gynecologic clinics six month post operation for vaginal sonographic evaluation of the uterine scar and for filling questionnaire concerning possibility of uterine scar defect ( spotting, pelvic pain, fertility abnormalities ).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
130
Inclusion Criteria
  • Term pregnancy (≥37 weeks of gestation)
  • Elective CS
Exclusion Criteria
  • Uterine scar
  • Thrombophilia
  • Dysmorphic uterus
  • Connective tissue disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Endometrial suturingVaginal ultrasonographyUterine incision repair including suturing of the endometrium
Non - Endometrial suturingVaginal ultrasonographyUterine incision repair without suturing of the endometrium
Endometrial suturingEndometrial suturingUterine incision repair including suturing of the endometrium
Endometrial suturingQuestionnaireUterine incision repair including suturing of the endometrium
Non - Endometrial suturingQuestionnaireUterine incision repair without suturing of the endometrium
Non - Endometrial suturingNon- endometrial suturingUterine incision repair without suturing of the endometrium
Primary Outcome Measures
NameTimeMethod
Number of participants with uterine scar defect six month post cesarean sectionUntil six month post cesarean section, and through study completion, an average of 1 year

Uterine scar defect with residual myometrium thickness of less then 2.5 mm

Secondary Outcome Measures
NameTimeMethod
SpottingThrough study completion, an average of 1 year

The rate of spotting complains since operation reported by the women

Abdominal painThrough study completion, an average of 1 year

The rate of abdominal pain since operation reported by the women and estimated by "The Visual Analogue Scale" (VAS) for the estimation of pain. In this scale, women will be asked to mark the pain that they are experiencing on a 10cm-long horizontal line labeled "no pain" on the far left and "worst pain ever" on the far right. Pain intensity is determined by the length of the line as measured from the left-hand side to the point marked. The following cut points on the pain VAS will be use: no pain (0-0.4 cm), mild pain (0.5-4.4 cm), moderate pain (4.5-7.4 cm), and severe pain (7.5-10 cm).

Trial Locations

Locations (1)

Dr. Aya Mohr-Sasson

🇮🇱

Ramat-Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath